Keyword: GlaxoSmithKline

GSK is grouping some non-core consumer products into three portfolios for sell-offs so it can win EU antitrust clearance for its Pfizer deal.

GSK's consumer health chief digital officer Marc Speichert talks about the creative inspiration and partner opportunities at Lions Health.

Breztri Aerosphere, AZ's three-in-one COPD inhaler, just won its first global nod to rival GlaxoSmithKline's Trelegy Ellipta.

GlaxoSmithKline, its agency McCann Health and their "Breath of LIfe" smartphone app took the Grand Prix in pharma last night at Cannes Lions Health.

As Lions Health wrapped up another year, attendees sifted their notes and pulled out a few common threads. Here are the ones we gathered.

Why did GSK tweak its strict ethics measures for sales reps? When it first nixed incentive-based compensation, it thought other pharmas would, too.

GlaxoSmithKline’s Nucala has suffered against a more convenient AstraZeneca rival, but the company finally has an answer.

The Discovery Labs is forming a $500 million healthcare and life sciences tech co-working community at a former GSK facility in Pennsylvania.

GSK prevailed in its Paxil preemption case as the Supreme Court denied taking up a lower court's decision to throw out a $3 million jury verdict.

India's Lupin faces new FDA concerns at its plant in Goa, and the FDA says it is making strides in improving pharmaceutical quality across the globe.